Koch R - Search Results

1

Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis.

Shumilov E, Aperdannier L, Schmidt N, Szuszies C, Neesse A, Hoffknecht P, Khandanpour C, Mikesch JH, Stelljes M, Boeckel GR, Tepasse PR, Reitnauer L, Koch R, Hasenkamp J, Bacher U, Scheithauer S, Trümper L, Schmitz N, Wulf G, Kerkhoff A, Lenz G, Krekeler C, Bleckmann A. Shumilov E, et al. Among authors: koch r. Cancers (Basel). 2022 Jul 31;14(15):3746. doi: 10.3390/cancers14153746. Cancers (Basel). 2022. PMID: 35954410 Free PMC article.

2

Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3.

Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, Weinhage T, Menck K, Hupfeld T, Koch R, Trümper L, Wulf GG. Aung T, et al. Among authors: koch r. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15336-41. doi: 10.1073/pnas.1102855108. Epub 2011 Aug 25. Proc Natl Acad Sci U S A. 2011. PMID: 21873242 Free PMC article.

3

Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapy.

Szuszies CJ, Hasenkamp J, Jung W, Koch R, Trümper L, Wulf GG. Szuszies CJ, et al. Among authors: koch r. Int J Hematol. 2014 Nov;100(5):425-8. doi: 10.1007/s12185-014-1678-8. Epub 2014 Sep 26. Int J Hematol. 2014. PMID: 25258193

4

Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia.

Shumilov E, Hasenkamp J, Szuszies CJ, Koch R, Wulf GG. Shumilov E, et al. Among authors: koch r. Acta Haematol. 2021;144(1):105-110. doi: 10.1159/000506302. Epub 2020 Apr 7. Acta Haematol. 2021. PMID: 32259827

5

Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers.

Shumilov E, Hoffknecht P, Koch R, Peceny R, Voigt S, Schmidt N, Peeck M, Bacher U, Scheithauer S, Trümper L, Lenz G, Kerkhoff A, Bleckmann A. Shumilov E, et al. Among authors: koch r. Cancers (Basel). 2021 Jun 11;13(12):2917. doi: 10.3390/cancers13122917. Cancers (Basel). 2021. PMID: 34208007 Free PMC article.

6

Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.

Shumilov E, Hasenkamp J, Maulhardt M, Mazzeo P, Schmidt N, Boyadzhiev H, Jung W, Ganster C, Haase D, Koch R, Wulf G. Shumilov E, et al. Among authors: koch r. Hematol Oncol. 2022 Oct;40(4):763-776. doi: 10.1002/hon.2995. Epub 2022 Apr 18. Hematol Oncol. 2022. PMID: 35368106

7

ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug.

Chapuy B, Panse M, Radunski U, Koch R, Wenzel D, Inagaki N, Haase D, Truemper L, Wulf GG. Chapuy B, et al. Among authors: koch r. Haematologica. 2009 Nov;94(11):1528-36. doi: 10.3324/haematol.2009.008631. Haematologica. 2009. PMID: 19880777 Free PMC article.

8

Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma.

Koch R, Demant M, Aung T, Diering N, Cicholas A, Chapuy B, Wenzel D, Lahmann M, Güntsch A, Kiecke C, Becker S, Hupfeld T, Venkataramani V, Ziepert M, Opitz L, Klapper W, Trümper L, Wulf GG. Koch R, et al. Blood. 2014 Apr 3;123(14):2189-98. doi: 10.1182/blood-2013-08-523886. Epub 2014 Feb 21. Blood. 2014. PMID: 24563408 Free article.

9

Controversies in the Treatment of Peripheral T-cell Lymphoma.

Bachy E, Broccoli A, Dearden C, de Leval L, Gaulard P, Koch R, Morschhauser F, Trümper L, Zinzani PL. Bachy E, et al. Among authors: koch r. Hemasphere. 2020 Sep 1;4(5):e461. doi: 10.1097/HS9.0000000000000461. eCollection 2020 Oct. Hemasphere. 2020. PMID: 33062943 Free PMC article. Review.

10

And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept.

Habermann FOJ, Schmitt D, Failing T, Ziegler DA, Fischer J, Fischer LA, Guhlich M, Bendrich S, Knaus O, Overbeck TR, Treiber H, von Hammerstein-Equord A, Koch R, El Shafie R, Rieken S, Leu M, Dröge LH. Habermann FOJ, et al. Among authors: koch r. Cancers (Basel). 2024 Jan 4;16(1):231. doi: 10.3390/cancers16010231. Cancers (Basel). 2024. PMID: 38201658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,957 results

Search Page